A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

ABSTRACT: Picoplatin is a new platinum-based chemotherapy drug that has been studied in a variety of cancers. Phase 1 and 2 studies have demonstrated that picoplatin may be effective in patients whose cancer returns or does not improve after treatment with chemotherapy. In these studies, picoplatin was administered intravenously. A capsule containing picoplatin has been formulated. This study will investigate the activity of the oral capsule in humans. Participants with advanced solid tumors will be enrolled.

DISEASE(S): Gastrointestinal Neoplasm,Lung Cancer,Solid Tumor,Gastrointestinal Neoplasms,Sarcoma,Colorectal Cancer,Bladder Cancer,Pancreatic Cancer,Breast Cancer,Ovarian Cancer,Prostate Cancer,Head And Neck Cancer,Digestive System Neoplasms,Cancer

PROVIDER: 2039408 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR